Literature DB >> 17237571

Low magnesium concentration in erythrocytes of children with acute asthma.

Mostafa Sedighi1, Zahra Pourpak, Behrouz Bavarian, Reza Safaralizadeh, Ahad Zare, Mostafa Moin.   

Abstract

Magnesium (Mg) is the second most abundant intracellular cation and is involved in numerous physiological functions, including protein folding, intracellular signaling and enzyme catalysis. It has been shown that magnesium deficiency exacerbates pulmonary airways hyper reactivity. Several studies suggest that magnesium level has no effect on asthma but others had shown a contributory effect. Because of its intracellular abundance the aim of this study was to determine if there was any difference in plasma and intracellular Mg concentrations of children with acute asthma compared to non asthmatic children. Twenty nine patients with acute asthma aged 2 to11 years admitted to the emergency department of hospital and 37 non asthmatic children with the same age were included in our study. 0.5 mL of heparinized whole blood samples of patients who were meeting inclusion criteria at the onset of admission with bronchoconstriction and before using any medication was drawn and it was immediately sent to the laboratory. Plasma and erythrocytes were separated and stored at -20C and later their Mg levels were quantified with atomic absorption spectrophotometry method. The average plasma and intracellular magnesium levels in patients were (0.79 +/- 0.098 mmol/L) and (1.17 +/- 0.27 mmol/L) respectively. Results of 37 non asthmatic persons [plasma (0.85 +/- 0.1 mmol/L ) and erythrocytes (1.33 +/- 0.21 mmol/L)] showed that there was no significant difference between plasma Mg levels in two groups (p 0.06) but intracellular magnesium level was significantly lower (p 0.03) in patients group. These results indicate that intracellular Mg level may be a more accurate method to assess Mg level in patients with asthma. Hence, determination of Mg concentration in erythrocytes may be used in evaluation of asthma pathophysiology. There are recommendations for using intravenous Mg sulfate in acute asthma, and this study supports the rational for using it in emergency departments for acute severe asthma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17237571     DOI: 05.04/ijaai.183186

Source DB:  PubMed          Journal:  Iran J Allergy Asthma Immunol        ISSN: 1735-1502            Impact factor:   1.464


  6 in total

1.  Relationship between Intracellular Magnesium Level, Lung Function, and Level of Asthma Control in Children with Chronic Bronchial Asthma.

Authors:  Htwe Htwe Sein; Cheah Whye Lian; Kok Juan Loong; Josephine Sl Ng; Andy Rahardjai; Mohamed Ameenudeen Sultan
Journal:  Malays J Med Sci       Date:  2014 Sep-Oct

Review 2.  Searching for Better Asthma Control?

Authors:  Jagdish Prasad Goyal; Prawin Kumar
Journal:  Indian J Pediatr       Date:  2018-04-09       Impact factor: 1.967

3.  Serum Total Magnesium Level and its Correlation with Symptom Control in Children with Mild Persistent Asthma.

Authors:  Pavani Chitamanni; Venkatesh Chandrasekaran; Soundravally Rajendiran
Journal:  Indian J Pediatr       Date:  2018-01-19       Impact factor: 1.967

4.  Acute Effect of Intravenous Administration of Magnesium Sulfate on Serum Levels of Interleukin-6 and Tumor Necrosis Factor-α in Patients Undergoing Elective Coronary Bypass Graft With Cardiopulmonary Bypass.

Authors:  Parastou Aryana; Samira Rajaei; Abdolhamid Bagheri; Forouzan Karimi; Ali Dabbagh
Journal:  Anesth Pain Med       Date:  2014-06-17

Review 5.  The role of oral magnesium supplements for the management of stable bronchial asthma: a systematic review and meta-analysis.

Authors:  Faisal Abuabat; Abdulaziz AlAlwan; Emad Masuadi; Mohammad Hassan Murad; Hamdan Al Jahdali; Mazen Saleh Ferwana
Journal:  NPJ Prim Care Respir Med       Date:  2019-02-18       Impact factor: 2.871

6.  Magnesium concentration in acute asthmatic children.

Authors:  Maha Amin; Mohammed Abdel-Fattah; Safa S Zaghloul
Journal:  Iran J Pediatr       Date:  2012-12       Impact factor: 0.364

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.